Research Article

VACCINE OPPOSAL IN PEOPLE OVER 60 YEARS OF AGE IN MARDIN/TURKEY – A TERRITORY WITH LOW RATE OF VACCINATION

Volume: 12 Number: 1 January 15, 2022
EN TR

VACCINE OPPOSAL IN PEOPLE OVER 60 YEARS OF AGE IN MARDIN/TURKEY – A TERRITORY WITH LOW RATE OF VACCINATION

Abstract

Objective: One of the most important public health practices in the prevention of communicable diseases is vaccination. In this study, it was desired to evaluate the vaccination attitude of individuals over the age of 60 years in cities where the rate of vaccination against COVID-19 was low rate. Material and Methods: Our research was carried out by reaching 396 people over the age of 60 in MardinTurkey. A questionnaire including the positive and negative attitudes of the participants towards the vaccine was filled in by face to face interviews. Results: We found that 110 (45.8%) of the participants who have not been innoculated in the provinces where the study was conducted did not trust the vaccine. Again, it was seen that 128 (53.3%) of those who did not get inoculated were illiterate and 68 (28.3%) were primary school graduates. There were no university graduates in the group that did not receive the vaccine. When positive and negative attitudes were evaluated, it was seen that 64 (16.2%) people strongly disagree with the positive attitude, I would like to be vaccinated at the first opportunity, and 48 (12.1%) strongly disagree with the positive attitude, I think everyone should be vaccinated. When the positive attitude of I trust the studies about the vaccine was examined, it was seen that 108 (27.3%) people gave the answer of strongly disagree. Again, it was seen that 53.3% of the participants who did not get vaccinated were illiterate and 28.3% were primary school graduates. Conclusion: The high level of concern about vaccine safety needs to be addressed. Future introduction of the vaccine should address these concerns, and a properly and thoroughly tested vaccine will help win the public's trust. In addition, campaigns should be organized to target low-educational groups, and they should be informed, due to the increase in the fear of vaccination as the level of education decreases.

Keywords

Supporting Institution

YOK

References

  1. 1. M Kabak, B Çil, I Hocanlı. Relationship between leukocyte, neutrophil, lymphocyte, platelet counts, and neutrophil to lymphocyte ratio and polymerase chain reaction positivity. Int Immunopharmacol. 2021 Apr;93:107390.
  2. 2. B Çil, M Kabak.THE POSSIBLE FACTORS THAT AFFECT THE CLINICAL SEVERITY AND MORTALITY OF COVID PNEUMONIA. Acta Medica Mediterranea, 2020, 36: 3655.
  3. 3. Qiang Gao, Linlin Bao, Haiyan Mao, Lin Wang et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science 2020, 369, 77–81.
  4. 4. Rafael Prieto Curiel, Humberto González Ramírez. Vaccination Strategies Against Covıd 19 And The Difusion Of Anti Vaccination Views. Sci Rep. 2021; 11: 6626.
  5. 5. Neha Puri, Eric A Coomes, Hourmazd Haghbayan, Keith Gunaratne. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Human Vaccines & Immunotherapeutics, 16:11, 2586-2593.
  6. 6. Geniş, Bahadır & Gürhan, Nermin & Koç, Medine & Geniş, Çiğdem & Şirin, Burak & Çırakoğlu, Okan & Coşar, Behcet. (2020). Development of Perception and Attitude Scales Associated with the COVID-19 Pandemic. 7. Brit Trogen, David Oshinsky, Arthur Caplan. Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust. JAMA 2020, 323, 2460–2461.
  7. 8. Jarrett, C.; Wilson, R.; O’Leary, M.; Eckersberger, E.; Larson, H.J.; the SAGE Working Group on Vaccine Hesitancy. Strategies for addressing vaccine hesitancy—A systematic review. Vaccine 2015, 33, 4180–4190.
  8. 9. Sadaf, A.; Richards, J.L.; Glanz, J.; Salmon, D.A.; Omer, S.B. A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy. Vaccine 2013, 31, 4293–4304.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

January 15, 2022

Submission Date

November 16, 2021

Acceptance Date

November 22, 2021

Published in Issue

Year 2022 Volume: 12 Number: 1

APA
Başaran, A., & Çil, B. (2022). VACCINE OPPOSAL IN PEOPLE OVER 60 YEARS OF AGE IN MARDIN/TURKEY – A TERRITORY WITH LOW RATE OF VACCINATION. Journal of Contemporary Medicine, 12(1), 81-85. https://doi.org/10.16899/jcm.1024259
AMA
1.Başaran A, Çil B. VACCINE OPPOSAL IN PEOPLE OVER 60 YEARS OF AGE IN MARDIN/TURKEY – A TERRITORY WITH LOW RATE OF VACCINATION. J Contemp Med. 2022;12(1):81-85. doi:10.16899/jcm.1024259
Chicago
Başaran, Alev, and Barış Çil. 2022. “VACCINE OPPOSAL IN PEOPLE OVER 60 YEARS OF AGE IN MARDIN TURKEY – A TERRITORY WITH LOW RATE OF VACCINATION”. Journal of Contemporary Medicine 12 (1): 81-85. https://doi.org/10.16899/jcm.1024259.
EndNote
Başaran A, Çil B (January 1, 2022) VACCINE OPPOSAL IN PEOPLE OVER 60 YEARS OF AGE IN MARDIN/TURKEY – A TERRITORY WITH LOW RATE OF VACCINATION. Journal of Contemporary Medicine 12 1 81–85.
IEEE
[1]A. Başaran and B. Çil, “VACCINE OPPOSAL IN PEOPLE OVER 60 YEARS OF AGE IN MARDIN/TURKEY – A TERRITORY WITH LOW RATE OF VACCINATION”, J Contemp Med, vol. 12, no. 1, pp. 81–85, Jan. 2022, doi: 10.16899/jcm.1024259.
ISNAD
Başaran, Alev - Çil, Barış. “VACCINE OPPOSAL IN PEOPLE OVER 60 YEARS OF AGE IN MARDIN TURKEY – A TERRITORY WITH LOW RATE OF VACCINATION”. Journal of Contemporary Medicine 12/1 (January 1, 2022): 81-85. https://doi.org/10.16899/jcm.1024259.
JAMA
1.Başaran A, Çil B. VACCINE OPPOSAL IN PEOPLE OVER 60 YEARS OF AGE IN MARDIN/TURKEY – A TERRITORY WITH LOW RATE OF VACCINATION. J Contemp Med. 2022;12:81–85.
MLA
Başaran, Alev, and Barış Çil. “VACCINE OPPOSAL IN PEOPLE OVER 60 YEARS OF AGE IN MARDIN TURKEY – A TERRITORY WITH LOW RATE OF VACCINATION”. Journal of Contemporary Medicine, vol. 12, no. 1, Jan. 2022, pp. 81-85, doi:10.16899/jcm.1024259.
Vancouver
1.Alev Başaran, Barış Çil. VACCINE OPPOSAL IN PEOPLE OVER 60 YEARS OF AGE IN MARDIN/TURKEY – A TERRITORY WITH LOW RATE OF VACCINATION. J Contemp Med. 2022 Jan. 1;12(1):81-5. doi:10.16899/jcm.1024259

Cited By